You have 9 free searches left this month | for more free features.

Lung Injury

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sports Injury, Intermittent Fasting Trial in Bloomington (Soccer Heading, Intermittent Fasting)

Recruiting
  • Sports Injury
  • Intermittent Fasting
  • Soccer Heading
  • Intermittent Fasting
  • Bloomington, Indiana
    Indiana University School of Public Health
Feb 1, 2022

Moderate to Severe Secondary Hyperparathyroidism, Stage 5 Chronic Kidney Diseases Trial (Paricalcitol, Darbepoetin alfa)

Completed
  • Moderate to Severe Secondary Hyperparathyroidism
  • Stage 5 Chronic Kidney Diseases
  • (no location specified)
Jul 28, 2021

Lung Cancer Trial in Canada, United States (Single-fraction stereotactic body radiation therapy (SBRT), Multiple-fraction

Completed
  • Lung Cancer
  • Single-fraction stereotactic body radiation therapy (SBRT)
  • Multiple-fraction stereotactic body radiation therapy (SBRT)
  • Auburn, California
  • +37 more
Feb 21, 2020

Myocardial Ischemia Trial in Vienna (Heme arginate 3mg/kg, Heme arginate 1mg/kg, Placebo)

Completed
  • Myocardial Ischemia
  • Heme arginate 3mg/kg
  • +2 more
  • Vienna, Austria
    Medical University of Vienna
Jan 26, 2021

NSCLC Stage IIIB, NSCLC Stage IV, EGFR Gene Mutation Trial in France (Carboplatin + Pemetrexed + Atezolizumab + Bevacizumab,

Recruiting
  • NSCLC Stage IIIB
  • +4 more
  • Carboplatin + Pemetrexed + Atezolizumab + Bevacizumab
  • Carboplatin + Pemetrexed + Atezolizumab
  • Angers, France
  • +30 more
Jun 7, 2021

Acute Kidney Injury, Contrast Media Toxicity, Curcuminoid Trial in Bangkok (Curcuminoid, Placebo)

Completed
  • Acute Kidney Injury
  • +3 more
  • Bangkok, Thailand
    Navamindradhiraj University
May 13, 2021

Muscle Spasticity Trial in United States (XP19986 SR1, 10 mg BID, XP19986 SR1, 20 mg BID, XP19986 SR1, 30 mg BID)

Completed
  • Muscle Spasticity
  • XP19986 SR1, 10 mg BID
  • +3 more
  • Downey, California
  • +10 more
Feb 17, 2021

Neoadjuvant Immune Checkpoint Inhibitor Combined With

Recruiting
  • Non-small Cell Lung Cancer
    • Hangzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Jun 21, 2021

    Burns, Infection Wound, Bacterial Infections Trial in Lubbock (Open-to-air strategy, Traditional closed-wound management)

    Withdrawn
    • Burns
    • +2 more
    • Open-to-air strategy
    • Traditional closed-wound management
    • Lubbock, Texas
      Texas Tech University Health Sciences Center
    Dec 14, 2021

    Thrombotic Thrombocytopenic Purpura Trial (Aspirin tablet, Placebo)

    Not yet recruiting
    • Thrombotic Thrombocytopenic Purpura
    • Aspirin tablet
    • Placebo
    • (no location specified)
    Sep 30, 2022

    Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease Trial in Worldwide (PRA023 IV, Companion diagnostic ( CDx),

    Recruiting
    • Diffuse Cutaneous Systemic Sclerosis
    • Interstitial Lung Disease
    • PRA023 IV
    • +2 more
    • Los Angeles, California
    • +13 more
    Jul 12, 2022

    Aortic Dissection Trial in Japan, United States (Endovascular Treatment (Zenith))

    Completed
    • Aortic Dissection
    • Endovascular Treatment (Zenith)
    • Los Angeles, California
    • +23 more
    Feb 23, 2021

    Cardiovascular Disease Among African Americans

    Enrolling by invitation
    • Cardiovascular Diseases
    • +5 more
      • Jackson, Mississippi
        UMMC, JSU, Tougaloo College, MSDH
      Dec 13, 2021

      Cancer Trial in Baltimore (Exercise Rehabilitation, Control)

      Recruiting
      • Cancer
      • Exercise Rehabilitation
      • Control
      • Baltimore, Maryland
        Baltimore VA Medical Center VA Maryland Health Care System, Balt
      Jan 6, 2022

      Lung Cancer, Bone Metastases, Single Cell Sequencing Technology Trial in Shanghai (model treatment, routine treatment)

      Recruiting
      • Lung Cancer
      • +2 more
      • model treatment
      • routine treatment
      • Shanghai, Other (Non U.s.), China
        Shanghai Sixth People'S Hospital
      Aug 9, 2021

      Tumors, NSCLC Trial (Epacadostat 25 mg, Epacadostat 100 mg, pembrolizumab 200 mg)

      Completed
      • Neoplasms
      • Carcinoma, Non-Small-Cell Lung
      • Epacadostat 25 mg
      • +7 more
      • (no location specified)
      Aug 17, 2022

      Search for New Methods to Detect Acute Renal Failure

      Recruiting
      • Kidney Disease
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        NSCLC, Immunotherapy Trial in Belgium ((chemo)immunotherapy)

        Recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Immunotherapy
        • Brussels, Belgium
        • +4 more
        Aug 20, 2021

        ctDNA in Cancer Early Detection and STAS Evaluation in GGOs

        Not yet recruiting
        • Lung Cancer
        • +2 more
        • cf DNA and ct DNA
        • Roma, Italy
          Thoracic Surgery Unit, Sapienza University of Rome
        Mar 31, 2022

        Postoperative Respiratory Complications Trial in Umeå (Positive airway pressure (PEP), Speaking loudly during about 3 minutes,

        Completed
        • Postoperative Respiratory Complications
        • Positive airway pressure (PEP)
        • +2 more
        • Umeå, Umea, Sweden
          Dept of Surgery, Inst of Surgical and Perioperative sciences
        Mar 19, 2022

        Gait Adaptability: Tracking Locomotor Recovery After Incomplete

        Recruiting
        • Gait Disorders, Neurologic
        • Gait Disorder, Sensorimotor
        • Standard locomotor therapy
        • Zürich, Switzerland
          Universitätsklinik Balgrist
        Jul 28, 2021

        Stage IV Small Cell Lung Cancer Trial in United States (OMP-59R5, Etoposide, Placebo)

        Terminated
        • Stage IV Small Cell Lung Cancer
        • Rogers, Arkansas
        • +34 more
        Sep 7, 2020

        Dry Eye Disease Trial in United States (Lifitegrast, Placebo)

        Completed
        • Dry Eye Disease
        • Birmingham, Alabama
        • +40 more
        Jun 2, 2021

        Endothelial Dysfunction, Hemolysis, Fluid Overload Trial in Amsterdam (A: gelofusine + ringers, B: albumine + ringers, C:

        Not yet recruiting
        • Endothelial Dysfunction
        • +2 more
        • A: gelofusine + ringers
        • +2 more
        • Amsterdam, Noord Holland, Netherlands
          Amsterdam UMC, AMC location
        Dec 9, 2022

        Endothelial Dysfunction, Hemolysis, Fluid Overload Trial in Amsterdam (Treatment: additional albumin during cardiopulmonary

        Not yet recruiting
        • Endothelial Dysfunction
        • +2 more
        • Treatment: additional albumin during cardiopulmonary bypass
        • control: additional ringers during cardiopulmonary bypass
        • Amsterdam, Noord Holland, Netherlands
          Amsterdam UMC, AMC location
        Dec 9, 2022